Hospital
Columbia Ogden Medical Center, INC.
Columbia Ogden Medical Center, INC. was paid $17.57M by Medicaid between Jan 2018 and Nov 2024, across 163 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 68% of everything it billed.
33Billing provider infoCOLUMBIA OGDEN MEDICAL CENTER, INC.
OGDEN, UT 84405
OGDEN, UT 84405
33aNPI1720031636assigned 05/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.57M
24GClaims328,382
24DCodes billed163
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Utah
Rank by total paid#4 of 26
Median peer was paid$6.14M
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,698 | $2.47M | |
| 2019 | 61,160 | $2.53M | |
| 2020 | 58,035 | $3.30M | |
| 2021 | 71,587 | $4.08M | |
| 2022 | 72,541 | $4.65M | |
| 2023 | 7,482 | $401K | |
| 2024incomplete | 1,879 | $137K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 68% | 38,156 | 18,907 | $11.97M |
| 36415 | Collection of venous blood by venipuncture | 11% | 21,014 | 16,867 | $1.91M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.9% | 15,815 | 13,838 | $508K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.1% | 19,396 | 16,282 | $368K |
| 80053 | Comprehensive metabolic panel | 1.4% | 17,406 | 14,337 | $247K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 4,877 | 4,392 | $233K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 820 | 730 | $193K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 1,377 | 1,233 | $184K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,944 | 1,613 | $168K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,714 | 2,341 | $126K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,605 | 3,095 | $117K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,741 | 1,442 | $106K |
151 more codes
| 81003 | <1% | 4,550 | $98K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,867 | $94K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,770 | $91K |
| 87400 | <1% | 2,310 | $90K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,590 | $79K |
| 81001 | <1% | 8,441 | $75K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,708 | $73K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 558 | $73K |
| 87430 | <1% | 1,493 | $52K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 555 | $45K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 2,995 | $37K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,950 | $36K |
| 73610 | <1% | 488 | $35K | |
| 73562 | <1% | 446 | $34K | |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 1,128 | $30K |
| 87070 | <1% | 1,755 | $25K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,329 | $25K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,469 | $24K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 643 | $24K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,264 | $22K |
| 73630 | <1% | 340 | $21K | |
| 73110 | <1% | 217 | $21K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 64 | $18K |
| 99285 | Emergency room visit (most serious) | <1% | 2,656 | $18K |
| J3490 | Unclassified drugs | <1% | 15 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,675 | $17K |
| 73130 | <1% | 196 | $17K | |
| 87077 | <1% | 2,026 | $16K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 580 | $14K |
| 81025 | <1% | 2,472 | $11K | |
| 73030 | <1% | 150 | $11K | |
| 85027 | <1% | 22,378 | $11K | |
| 87420 | <1% | 469 | $11K | |
| 80047 | <1% | 1,305 | $11K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 352 | $10K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,488 | $9K |
| 12001 | <1% | 74 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,485 | $7K |
| G0378 | Hospital observation service, per hour | <1% | 1,347 | $6K |
| 87486 | <1% | 93 | $6K | |
| 76376 | <1% | 67 | $5K | |
| 84484 | <1% | 5,386 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 108 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,044 | $4K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 150 | $4K |
| 93971 | <1% | 244 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,056 | $4K |
| 72100 | <1% | 92 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,334 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 474 | $4K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 735 | $3K |
| 83690 | <1% | 6,562 | $3K | |
| 31720 | <1% | 178 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 69 | $3K |
| 12011 | <1% | 25 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,220 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,552 | $3K |
| 84702 | <1% | 449 | $3K | |
| 94664 | <1% | 1,306 | $2K | |
| 84703 | <1% | 3,280 | $2K | |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 46 | $2K |
| 87490 | <1% | 154 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,667 | $2K |
| 83880 | <1% | 2,522 | $2K | |
| 87186 | <1% | 2,178 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,646 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,847 | $2K |
| 59025 | Fetal non-stress test | <1% | 925 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 155 | $2K |
| 82077 | <1% | 1,468 | $2K | |
| 87081 | <1% | 176 | $2K | |
| 93970 | <1% | 32 | $1K | |
| 12002 | <1% | 13 | $1K | |
| 82550 | <1% | 689 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 984 | $1K |
| 87040 | <1% | 2,011 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 97 | $1K |
| 73090 | <1% | 13 | $1K | |
| 80061 | Lipid panel | <1% | 320 | $883.18 |
| 74018 | <1% | 27 | $801.20 | |
| 86850 | <1% | 261 | $776.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,029 | $772.91 |
| 82607 | <1% | 19 | $685.47 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 130 | $672.17 |
| 86900 | <1% | 597 | $659.40 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $637.46 |
| 85379 | <1% | 980 | $587.15 | |
| 85610 | <1% | 1,934 | $529.96 | |
| 83735 | <1% | 416 | $526.61 | |
| 73590 | <1% | 13 | $505.84 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,093 | $464.30 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 60 | $267.29 |
| 84481 | <1% | 16 | $265.39 | |
| 36000 | <1% | 349 | $240.07 | |
| 29125 | <1% | 12 | $215.84 | |
| 84439 | <1% | 129 | $178.64 | |
| 83605 | <1% | 2,359 | $177.80 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 268 | $169.75 |
| 70491 | <1% | 13 | $165.80 | |
| 87205 | <1% | 14 | $134.73 | |
| 93017 | <1% | 19 | $134.63 | |
| 86140 | <1% | 504 | $124.06 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 176 | $122.17 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 40 | $110.64 |
| 86803 | <1% | 15 | $108.12 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,572 | $89.68 |
| 80076 | <1% | 1,868 | $80.65 | |
| 82728 | <1% | 22 | $74.94 | |
| 96376 | <1% | 602 | $57.02 | |
| 83550 | <1% | 37 | $22.30 | |
| 87088 | <1% | 16 | $21.82 | |
| C1769 | Guide wire | <1% | 280 | $20.52 |
| 90715 | <1% | 83 | $19.88 | |
| 83540 | <1% | 39 | $17.78 | |
| 80143 | <1% | 996 | $14.17 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 521 | $11.42 |
| 87590 | <1% | 154 | $8.69 | |
| 85730 | <1% | 219 | $4.34 | |
| A9270 | Non-covered item or service | <1% | 2,580 | $3.70 |
| 86901 | <1% | 597 | $2.45 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,164 | $1.06 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 236 | $0.00 |
| 93976 | 0% | 172 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 216 | $0.00 |
| 80179 | 0% | 957 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 137 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 127 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 53 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 148 | $0.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 107 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 93 | $0.00 |
| 99152 | 0% | 88 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 14 | $0.00 |
| 84100 | 0% | 27 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 17 | $0.00 |
| 84550 | 0% | 13 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 91 | $0.00 |
| 87581 | 0% | 93 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 319 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 102 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 1,116 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 47 | $0.00 |
| 85651 | 0% | 93 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 847 | $0.00 |
| 76801 | 0% | 26 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 51 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 20 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 13 | $0.00 |
| 88304 | 0% | 12 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 27 | $0.00 |
| 97597 | 0% | 54 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHALE, MICHAEL (CFO)